256 related articles for article (PubMed ID: 35199014)
1. Subcutaneous ICD Implantation and Catheter Ablation: A Step-Planned Approach for Ventricular Tachycardia Management in ARVC.
Sanniti A; Zagari D; Renzullo E; Valeriano C; Moretti P; Spadacini G; Tritto M
JACC Case Rep; 2022 Feb; 4(4):185-191. PubMed ID: 35199014
[TBL] [Abstract][Full Text] [Related]
2. Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.
Al-Ghamdi B; Mallawi Y; Shafquat A; AlRuwaili N; Alhazaymeh A; Al-Manea W; Al-Fayyadh M
Cardiol Res; 2018 Aug; 9(4):204-214. PubMed ID: 30116448
[TBL] [Abstract][Full Text] [Related]
3. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
[TBL] [Abstract][Full Text] [Related]
4. Ventricular Flutter and Pleomorphic Ventricular Tachycardia-Induced Syncope in Borderline Arrhythmogenic Right Ventricular Cardiomyopathy.
Marcus M; Wu R; Link MS; Levine BD
JACC Case Rep; 2022 Sep; 4(17):1134-1139. PubMed ID: 36124153
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
[TBL] [Abstract][Full Text] [Related]
7. Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.
Oliveira M; Cunha P; Valente B; Portugal G; Lousinha A; Pereira M; Braz M; Delgado A; Ferreira RC
Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):865-873. PubMed ID: 34857160
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.
Orgeron GM; Bhonsale A; Migliore F; James CA; Tichnell C; Murray B; Bertaglia E; Cadrin-Tourigny J; De Franceschi P; Crosson J; Tandri H; Corrado D; Calkins H
J Am Heart Assoc; 2018 Nov; 7(21):e008782. PubMed ID: 30608223
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry.
Migliore F; Viani S; Bongiorni MG; Zorzi A; Silvetti MS; Francia P; D'Onofrio A; De Franceschi P; Sala S; Donzelli S; Ricciardi G; Menardi E; Giammaria M; La Greca C; Bauce B; Rigato I; Iliceto S; Bertaglia E; Diemberger I; Corrado D
Int J Cardiol; 2019 Apr; 280():74-79. PubMed ID: 30661851
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome.
Cheng WH; Chung FP; Lin YJ; Lo LW; Chang SL; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang TY; Kuo L; Wu CI; Liu CM; Liu SH; Chen SA
Rev Cardiovasc Med; 2021 Dec; 22(4):1295-1309. PubMed ID: 34957771
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
Al-Ghamdi B; Shafquat A; Mallawi Y
Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of ICD electrograms analysis to distinguish endocardial vs epicardial ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
Kodali S; Shirai Y; Callans DJ; Zado ES; Marchlinski FE; Santangeli P
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1526-1534. PubMed ID: 31187564
[TBL] [Abstract][Full Text] [Related]
17. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
Assis FR; Krishnan A; Zhou X; James CA; Murray B; Tichnell C; Berger R; Calkins H; Tandri H; Mandal K
Heart Rhythm; 2019 Jul; 16(7):1003-1010. PubMed ID: 30677492
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation.
Komura M; Suzuki J; Adachi S; Takahashi A; Otomo K; Nitta J; Nishizaki M; Obayashi T; Nogami A; Satoh Y; Okishige K; Hachiya H; Hirao K; Isobe M
Int Heart J; 2010 Jan; 51(1):34-40. PubMed ID: 20145349
[TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
20. Reinitiation of ventricular macroreentry within the His-Purkinje system by back-up ventricular pacing - a mechanism of ventricular tachycardia storm.
Reithmann C; Hahnefeld A; Oversohl N; Ulbrich M; Remp T; Steinbeck G
Pacing Clin Electrophysiol; 2007 Feb; 30(2):225-35. PubMed ID: 17338720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
